Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
AstraZeneca pays $185M upfront to reenter oral obesity gold rush, drops phase 2 sickle cell drug After terminating an internal GLP-1 program this summer, AstraZeneca has agreed to pay Eccogene $185 million for the Chinese biotechs early-phase, once-daily oral GLP-1 agonist
Those names can be useful shorthand, but they do not tell you enough by themselves
The lower concentration means larger injection volumes for a given dose, which can actually help with accuracy when using standard insulin syringes
The scientific case for it: A study at the University of Hull, England, found that acute caffeine ingestion significantly increased time to exhaustion in an endurance exercise test
US$ 24.10
US$ 24.82
US$ 26.91
US$ 22.20
US$ 21.00
